If you’re taking oral vancomycin for your PSC, there are three documents you NEED to be aware of. Understanding these three documents may help you access oral vancomycin from a physician and from your insurance. All three documents are associated with the American Association for the Study of Liver Diseases (AASLD). Let’s take a deep […]
How the AASLD’s Guidance and Support Statement Will Impact the PSC Community’s Access to Oral Vancomycin
On September 9, 2022, the American Association for the Study of Liver Diseases (AASLD) officially published their PSC Guidance as well as an Support Statement. In this post, I’m going to share why the Guidance for the oral vancomycin section is negative, why the Support Statement is positive, and what this means for PSC patients […]
Oral Vancomycin for PSC: How the Updated AASLD Guidance May Impact Your Ability to Access Vancomycin
In early July 2022, I learned from the American Association for the Study of Liver Disease (AASLD) that they’ll be updating their PSC Guidance to limit the use of oral vancomycin to clinical trials. Their Guidance will also state that treating IBD associated with PSC is outside their scope. If this AASLD Guidance passes, insurance […]